Dr Pavlovsky speaks with ecancer at EHA 23 to discuss treatment options for relapsed Hodgkin lymphoma.

She outlines suitability of maintenance therapy with brentuximab verdotin for some patients, offering improved survival and response, and recent advances in checkpoint immunotherapy.

Dr Pavlovsky also highlights patients for whom stem cell transplantation may an option.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.